Demandez un entretien de conseil sur les cellules souches
En savoir plus
Contactez-nous dès aujourd'hui !
Vous souhaitez en savoir plus sur nos services ? Remplissez le formulaire ci-dessous et nous vous contacterons dans les plus brefs délais afin de vous fournir toutes les informations nécessaires et de répondre à vos questions.
Résumé des patients traités
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr.
Source
Type de source
Diagnostic
Domaine médical
Année d’application
Thérapie
Pays
Âge du bénéficiaire
3901
Apheresis
Allogeneic
Lymphoma
Hematology
2021
Standard Therapy
Poland
58
3902
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
66
3903
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
57
3904
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
66
3905
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
57
3906
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
63
3907
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
56
3908
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
65
3909
Apheresis
Allogeneic
Metachromatic Leukodystrophy
Hematology
2021
Standard Therapy
Poland
60
3910
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
36
3911
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
50
3912
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
21
3913
Apheresis
Allogeneic
Mucopolysaccharidosis
Hematology
2021
Standard Therapy
Poland
2
3914
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2021
Standard Therapy
Poland
44
3915
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2021
Standard Therapy
Poland
60
3916
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3917
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
71
3918
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
53
3919
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
51
3920
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3921
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3922
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3923
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3924
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
66
3925
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
50
3926
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3927
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
50
3928
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
47
3929
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
43
3930
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
66
3931
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
56
3932
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3933
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
51
3934
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3935
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3936
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3937
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3938
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3939
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
38
3940
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3941
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
63
3942
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
71
3943
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
52
3944
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
63
3945
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3946
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3947
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3948
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
58
3949
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3950
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
60
3951
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
58
3952
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
67
3953
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3954
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
42
3955
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3956
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
67
3957
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3958
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3959
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3960
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
41
3961
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
60
3962
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
8
3963
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
61
3964
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
62
3965
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3966
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3967
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
56
3968
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
62
3969
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
57
3970
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
47
3971
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3972
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
29
3973
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
66
3974
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3975
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3976
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
59
3977
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
50
3978
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
59
3979
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
28
3980
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3981
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3982
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
54
3983
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
66
3984
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
52
3985
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3986
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
75
3987
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
72
3988
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
62
3989
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
40
3990
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3991
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
67
3992
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
72
3993
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
64
3994
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
64
3995
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
53
3996
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
53
3997
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
73
3998
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3999
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
8
4000
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
66